XM does not provide services to residents of the United States of America.
B
B

Brenntag


News

Berenberg ups Brenntag on 'realistic' consensus, strategy shift

BUZZ-Berenberg ups Brenntag on 'realistic' consensus, strategy shift ** Berenberg raises Brenntag BNRGn.DE to "buy" from "hold", citing more realistic consensus numbers for 2025 and the company's shift in strategy away from pursuing a legal split of its Essentials and Specialties businesses ** Shares in the German chemicals distributor, which are down 30% YTD, rise around 3%, to the top of German blue-chip index .GDAXI ** "We think Brenntag's stock is now priced too pessimistically moving into F
B
G

Clarkson, Halma, SSE

EUROPE RESEARCH ROUNDUP-Clarkson, Halma, SSE Nov 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Clarkson, Halma and SSE, on Friday. HIGHLIGHTS * Clarkson Plc CKN.L : Berenberg initiates coverage with buy rating; PT 5075p * Halma HLMA.L : Barclays raises target price to 2925p from 2840p * Lindt & Spruengli LISP.S : Baader Helvea cuts PT to CHF 10,700 from CHF 11,200 * Sage Group SGE.L : Citigroup raises target price to 1450p fro
A
A
A
B
B
H
J
M
P
S
W
G
J
N
S
Z

Brenntag Says Artisan Partners Funds Holds 10.6% Of Total Voting Rights And Instruments In Co As Of Nov 13

BRIEF-Brenntag Says Artisan Partners Funds Holds 10.6% Of Total Voting Rights And Instruments In Co As Of Nov 13 Nov 19 (Reuters) - BRENNTAG SE BNRGn.DE : SAYS ARTISAN PARTNERS FUNDS HOLDS 10.6% OF TOTAL VOTING RIGHTS AND INSTRUMENTS IN BRENNTAG SE AS OF NOV 13 Source text: ID:nEQ2zNcmVa Further company coverage: BNRGn.DE (Gdansk Newsroom)
B

VCI Director-General: Urgent Problems In Germany Must Finally Be Solved

BRIEF-VCI Director-General: Urgent Problems In Germany Must Finally Be Solved Nov 13 (Reuters) - GERMANY'S CHEMICAL INDUSTRY ASSOCIATION VCI DIRECTOR-GENERAL: STEPS TO STIMULATE GROWTH IN THE U.S., SUCH AS TAX CUTS, COULD HAVE A POSITIVE IMPACT ON DEMAND FOR CHEMICALS VCI DIRECTOR-GENERAL: NO MATTER WHO SITS IN THE WHITE HOUSE: WE HOPE THAT THE U.S. WILL REMAIN A KEY TRADING PARTNER FOR GERMAN CHEMICAL AND PHARMACEUTICAL INDUSTRY IN COMING YEARS VCI DIRECTOR-GENERAL: POSSIBLE U.S.
B
B
L

Air Liquide, Evonik Industries, Sodexo

EUROPE RESEARCH ROUNDUP-Air Liquide, Evonik Industries, Sodexo Nov 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air Liquide, Evonik Industries and Sodexo on Wednesday. HIGHLIGHTS * Air Liquide AIRP.PA : Jefferies raises to buy from underperform * Evonik Industries AG EVKn.DE : Jefferies cuts to underperform from hold * Ibstock IBST.L : Deutsche Bank raises to buy from hold * Sodexo EXHO.PA : Berenberg raises target price to E
A
B
B
B
B
C
D
E
E
G
K
S
S
U
A
B
B
S

China jitters, earnings drag Europe's STOXX 600 to three-month low

UPDATE 2-China jitters, earnings drag Europe's STOXX 600 to three-month low For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Basic resources lead sectoral losses Trump and coalition collapse dent German investor morale Bayer sinks on 2025 earnings fall forecast UK's Convatec Group shares jump after FY24 guidance raise STOXX 600 down 2% Updated with closing levels By Shashwat Chauhan and Pranav Kashyap Nov 12 (Reuters) - Europe's main inde
A
B
B
C
I
M
T
E
F
U
G

Brenntag CEO Says Cost Reductions And Efficiency Improvements Are Currently The Priority - Conf Call

BRIEF-Brenntag CEO Says Cost Reductions And Efficiency Improvements Are Currently The Priority - Conf Call Nov 12 (Reuters) - BRENNTAG SE BNRGN.DE : CFO - COST REDUCTIONS IN 2024 EUR 50 TO 60 MILLION, TWICE AS HIGH IN 2025 -CONF CALL CEO - COST REDUCTIONS AND EFFICIENCY IMPROVEMENTS ARE CURRENTLY THE PRIORITY -CONF CALL CEO - WE FEEL WELL POSITIONE
B

Lots of results, investors aren't impressed

LIVE MARKETS-Lots of results, investors aren't impressed STOXX falls 0.9% Bayer 12% lower, Brenntag down 9.6% both after results U.S. share futures steady Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com LOTS OF RESULTS, INVESTORS AREN'T IMPRESSED It's been a busy first hour of trading, with a slew of corporate updates which, in combination, have left Europe's main share indexes t
A
B
B
E
F
U
G

Brenntag slumps to 23-month lows after Q3 miss

BUZZ-Brenntag slumps to 23-month lows after Q3 miss Updates shares, adds milestones, further analyst comment ** Shares in Brenntag BNRGn.DE fall about 9 % to their 23-month lows, as its quarterly core profit missed market expectations, due to higher volume driven costs and inflationary impacts ** Q3 operating EBITA fa lls 4.9% to 281.1 million euros ($298.84 million), missing Vara Research consensus of 292 million euros ** "Overall, a material miss in 3Q even vs.
B
G

Brenntag slides on Q3 profit miss

BUZZ-Brenntag slides on Q3 profit miss ** Brenntag's BNRGn.DE stock falls 3% in early Frankfurt trade as its quarterly core profit missed market expectations ** Operating EBITA fell 4.9% to 281.1 million euros ($298.84 million) in Q3, below the estimate of 292 million euros ** "Overall, a material miss in 3Q even vs. consensus which was substantial
B
G

Brenntag profit dragged by transport and digitalisation costs, shares slump

UPDATE 4-Brenntag sees 'neutral to slightly positive' impact from Trump re-election Sees 'neutral to slightly positive' impact from geopolitical changes after Trump's re-election Confirms 2024 outlook after two cuts earlier this year Q3 core profit falls 4.9%, missing consensus Shares down 8.2%, among worst performers on STOXX 600 Recasts with comments on Trump's re-election in paragraphs 1-5, updates share move By Ozan Ergenay and Tristan Veyet Nov 12 (Reuters) - German chemicals distributor Br
B

Brenntag reports Q3 core profit below expectations

Brenntag reports Q3 core profit below expectations Nov 12 (Reuters) - German chemicals distributor Brenntag BNRGn.DE reported a 4.9 % drop in its quarterly core profit on Tuesday, below market expectations, due to higher volume driven costs and inflationary impacts. The chemicals group posted operating earnings before interest, taxes and amortisation (EBITA) of 281.1 million euros ($298.9 million) for the third quarter, down from 302.7 million last year and below analysts' average forecast of 29
B

Brenntag Q3 Sales At EUR 4.07 Bln

BRIEF-Brenntag Q3 Sales At EUR 4.07 Bln Nov 12 (Reuters) - BRENNTAG SE BNRGn.DE : REPORTS VOLUME AND GROSS PROFIT GROWTH IN Q3 2024 GUIDANCE CONFIRMED REACHED Q3 SALES OF 4,068.8 MILLION REACHED Q3 SALES OF EUR 4,068.8 MILLION Q3 OPERATING GROSS PROFIT CAME IN AT 1,019.2 MILLION EUR Q3 OPERATING EBITA DECREASED BY 4.9% YEAR-ON-YEAR AND STOOD AT 281
B

Germany corporate earnings week ahead

DIARY-Germany corporate earnings week ahead Nov 8 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time(GMT) RIC Company Name Event Name 11-Nov-2024 BMO HNRGn.DE Hannover Rueck SE Q3 2024 Hannover Rueck SE Earnings Release 11-Nov-2024 06:30 CONG.DE Continental AG Q3 2024 Continental AG Earnings Release 12-Nov-2024 NTS BNRGn.DE Brenntag SE Q3 2024 Brenntag SE Earnings Release 12-Nov-2024 BMO IFXGn.DE Infineon Technologies AG Q4 2024 Inf
B
B
C
D
E
H
I
P
R
S
A
G

Brenntag Specialties To Distribute UV Protection Solutions For Skincare By Sarex

BRIEF-Brenntag Specialties To Distribute UV Protection Solutions For Skincare By Sarex Oct 29 (Reuters) - BRENNTAG SE BNRGn.DE : BRENNTAG SPECIALTIES CHOSEN AS DISTRIBUTOR FOR UV PROTECTION SOLUTIONS IN SKINCARE BY SAREX Further company coverage: [BNRGn.DE] (Gdansk Newsroom)
B

Brenntag CFO to leave in 2025, company says

Brenntag CFO to leave in 2025, company says Oct 29 (Reuters) - Brenntag's BNRGn.DE Chief Financial Officer Kristin Neumann will not extend her contract for personal reasons and will leave the company when her contract expires on March 31, 2025, the German chemicals distributor said on Tuesday. The company said that the Supervisory Board will decide on her successor in the near future, adding the orderly search process for the successor is underway.
B

Basler AG, Greatland Gold, Sandvik AB

EUROPE RESEARCH ROUNDUP-Basler AG, Greatland Gold, Sandvik AB Oct 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Basler AG, Greatland Gold and Sandvik AB, on Tuesday. HIGHLIGHTS * Autoneum Holding AG AUTON.S : UBS raises PT to CHF 170 from CHF 160 * Azelis NV AZE.BR : HSBC raises to buy from hold * Basler AG BSLG.DE : Jefferies cuts to hold from buy * Greatland Gold Plc GGPL.L : Berenberg cuts to hold from buy * Sandvik AB SAND
A
B
E
F
G
I
I
N
P
R
S
S
S
T
R

Top of the Street: Anglo American, Boliden, Brenntag, Wacker Chemie

BUZZ-Top of the Street: Anglo American, Boliden, Brenntag, Wacker Chemie A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Stifel raises German chemicals distributor Brenntag BNRGn.DE to "buy" from "hold" citing a potential upside to the stock price, and says it expects 2025 to be the second year of earnings recovery for the diversified chemicals sector ** J.P.Morgan cuts Anglo American AAL.L to "neutral" from "overweight" and Boliden BOL.ST to "underweigh
B
B
D
J
W
A

Anglo American, Boliden, Central Asia Metals

EUROPE RESEARCH ROUNDUP-Anglo American, Boliden, Central Asia Metals Oct 10 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Anglo American, Boliden and Central Asia Metals, on Thursday. HIGHLIGHTS * Anglo American AAL.L : JP Morgan cuts to neutral from overweight * Boliden AB BOL.ST : JP Morgan cuts to underweight from neutral * Central Asia Metals Plc CAML.L : Berenberg cuts to hold from buy * Fevertree Drinks Plc FEVR.L : Exane BN
A
A
A
A
B
B
B
C
D
H
I
M
M
N
P
S
V
A
A
A

Admiral, Capgemini, Zurich Insurance Group

EUROPE RESEARCH ROUNDUP- Admiral, Capgemini, Zurich Insurance Group Aug 22 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral, Capgemini and Zurich Insurance Group, on Thursday. HIGHLIGHTS * Admiral ADML.L : Jefferies raises to hold from underperform * Capgemini CAPP.PA : Jefferies cuts target price to EUR 185 from EUR 195 * Glenveagh Properties Plc GLV.I : Jefferies raises to buy from hold * Orsted ORSTED.CO : Deutsche Bank c
A
A
A
B
B
C
D
D
E
E
H
H
O
P
R
S
S
S
S
T
T
T
V
I
U
Z



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.